Claudin expression profiles in Epstein-Barr virus-associated nasopharyngeal carcinoma

Oncology Reports

Volumn 23, Issue 4, 2010, Pages 927-931

  Kojima, Fumiyoshi ^a   Ishida, Mitsuaki ^a   Takikita Suzuki, Mikiko ^a   Hotta, Machiko ^a   Katsura, Kanade ^b   Nagata, Akihiro ^c   Enoki, Yasuyuki ^c   Kato, Gen Ichi ^c   Okabe, Hidetoshi ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b KYOTO SECOND RED CROSS HOSPITAL   (Japan)

^c KYOTO FIRST RED CROSS HOSPITAL   (Japan)

Author keywords

Claudin; Epstein Barr virus; Nasopharyngeal carcinoma

Indexed keywords

CLAUDIN; CLAUDIN 1; CLAUDIN 2; CLAUDIN 3; CLAUDIN 4; ENTEROTOXIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLOSTRIDIUM PERFRINGENS; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; DISTANT METASTASIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CLAUDINS; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS;

EID: 77949458720     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000716     Document Type: Article

References (25)

1. Van Itallie CM and Anderson JM: Claudins and epithelial paracellular transport. Annu Rev Physiol 68: 403-429, 2006.
2. Krause G, Winkler L, Mueller SL, Haseloff RF, Piontek J and Blasig IE: Structure and function of claudins. Biochim Biophys Acta 1778: 631-645, 2007.
3. Hewitt KJ, Agarwal R and Morin PJ: The claudin gene family: expression in normal and neoplastic tissues. BMC Cancer 6: 186, 2006.
4. De Oliveira SS, De Oliveira IM, De Souza W and Morgado-Diaz JA: Claudins upregulation in human colorectal cancer. FEBS Lett 579: 6179-6185, 2005.
5. Kominsky SL, Vali M, Korz D, et al: Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4. Am J Pathol 164: 1627-1633, 2004.
6. Zhu Y, Brännström M, Janson PO and Sundfeldt K: Differences in expression patterns of the tight junction proteins, claudin 1, 3, 4 and 5, in human ovarian surface epithelium as compared to epithelia in inclusion cysts and epithelial ovarian tumors. Int J Cancer 118: 1884-1891, 2006.
7. Borka K, Kaliszky P, Szabo E, et al: Claudin expression in pancreatic endocrine tumors as compared with ductal adenocarcinomas. Virchows Arch 450: 549-557, 2007.
8. Väre P, Loikkanen I, Hirvikoski P, Vaarala MH and Soini Y: Low claudin expression is assciated with high Gleason grade in prostate adenocarcinoma. Oncol Rep 19: 25-31, 2008.
9. Sheehan GM, Kallakury BVS, Sheehan CE, Fisher HAG, Kaufman Jr RP and Ross JS: Loss of claudins-1 and -7 and expression of claudins-3 and -4 correlate with prognostic variables in prostatic adenocarcinomas. Hum Pathol 38: 564-569, 2007.
10. Moldvay J, Jäckel M, Paska C, Soltesz I, Schaff Z and Kiss A: Distinct claudin expression profile in histologic subtypes of lung cancer. Lung Cancer 57: 159-167, 2007.
11. Bello IO, Vilen ST, Niinimaa A, Kantola S, Soini Y and Salo T: Expression of claudins 1, 4, 5, and 7 and occludin, and relationship with prognosis in squamous cell carcinoma of the tongue. Hum Pathol 39: 1212-1220, 2008.
12. Takala H, Saarnio J, Wiik H and Soini Y: Claudins 1, 3, 4, 5 and 7 in esophageal cancer: loss of claudin 3 and 4 expression is associated with metastatic behavior. APMIS 115: 838-847, 2007.
13. Ishida M, Kushima R and Okabe H: Claudin expression in rectal well-differentiated endocrine neoplasms (carcinoid tumors). Oncol Rep 21: 113-117, 2009.
14. Chan JKC, Bray F, McCarron P, et al: Nasopharyngeal carcinoma. In: World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours. Barnes L, Eveson JW, Reichart P and Sidransky D (eds). IARC Press, Lyon, pp85-97, 2005.
15. Parkin DM, Bray F, Ferlay J and Pisani P: Estimating the world cancer burden: Globocan 2000. Int J Cancer 94: 153-156, 2001.
16. Shinozaki A, Ushiku T, Morikawa T, et al: Epstein-Barr virusassociated gastric carcinoma: a distinct carcinoma of gastric phenotype by claudin-expression profiling. J Histochem Cytochem 57: 775-785, 2009.
17. Morita K, Tsukita S and Miyachi Y: Tight junction-associated proteins (occludin, ZO-1, claudin-1, claudin-4) in squamous cell carcinoma and Bowen's disease. Br J Dermatol 151: 328-334, 2004.
18. Soini Y: Claudins 2, 3, 4 and 5 in Paget's disease and breast carcinoma. Hum Pathol 35: 1531-1536, 2004.
19. Lee AWM, Sze WM, Au JSK, et al: Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys 61: 1107-1116, 2005.
20. Teo P, Leung SF, Yu P, Lee WY and Shiu W: A retrospective comparison between different stage classifications for nasopharyngeal carcinoma. Br J Radiol 64: 901-908, 1991.
21. Cvitkovic E, Bachouchi M, Boussen H, et al: Leukemoid reaction, bone marrow invasion, fever of unknown origin, and metastatic pattern in the natural history of advanced undifferentiated carcinoma of nasopharyngeal type: a review of 255 consecutive cases. J Clin Oncol 11: 2434-2442, 1993.
22. Cvitkovic E, Bachouchi M and Armand JP: Nasopharyngeal carcinoma. Biology, natural history, and therapeutic implications. Hematol Oncol Clin North Am 5: 821-838, 1991.
23. Fujita K, Katahira J, Horiguchi Y, Sonoda N, Furuse M and Tsukita S: Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction integral membrane protein. FEBS Lett 476: 258-261, 2000.
24. Katahira J, Inoue N, Horiguchi Y, Matsuda M and Sugimoto N: Molecular cloning and functional characterization of the receptor for Clostridium perfringens enterotoxin. J Cell Biol 136: 1239-1247, 1997.
25. McClane BA and McDonel JL: Protective effects of osmotic stabilizers on morphological and permeability alterations induced in Vero cells by Clostridium perfringens enterotoxin. Biochim Biophys Acta 641: 401-409, 1981.